Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib helped a young woman's severe hair loss and arthritis but not her plaque psoriasis.

Some topical treatments like corticosteroids and vitamin D analogues are effective for scalp psoriasis, but more long-term data is needed.

Narrowband UVB treatment increases certain gene expressions in psoriasis skin and improves symptoms.

Tofacitinib treatment significantly improved a patient's psoriasis, psoriatic arthritis, and alopecia universalis.

Adalimumab is the most effective treatment for severe hidradenitis suppurativa, but more research is needed to improve treatment options.

Tofacitinib improved arthritis and partially improved hair loss in a lupus patient without side effects.

A patient experienced long-lasting hair loss after using acitretin for psoriasis.

Tildrakizumab may cause alopecia areata, but stopping it and using corticosteroids can regrow hair.

New insights into cell communication in psoriasis suggest innovative drug treatments.

SM04755 may be an effective topical treatment for psoriasis.

Exercise may help reduce treatment side effects and improve survival in metastatic colorectal cancer.

Propolis and aloe vera ointment effectively treats mild to moderate psoriasis.

Blood vessel patterns in skin diseases relate to certain blood markers in systemic sclerosis but not in psoriasis or psoriatic arthritis, and may indicate circulation issues in alopecia.

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

Young men taking finasteride for hair loss have a higher risk of sexual dysfunction.

Most patients with frontal fibrosing alopecia stabilized with treatment, especially younger ones, using intralesional corticosteroids and tacrolimus.

New treatments for a chronic skin condition show promise, but individualized plans are crucial due to varying responses.

Current treatments for Alopecia Areata are unsatisfactory and need improvement.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

New medications could improve treatment for severe alopecia areata in Australia.

Individualized treatment and psychological support improved the patient's quality of life and appearance despite medication side effects.

Frontal fibrosing alopecia can be managed with personalized combination therapies, but no cure exists yet.

Alopecia areata treatment should be personalized, using topical or systemic therapies based on severity, with promising options like JAK inhibitors needing more research.

Current treatments for folliculitis decalvans include antibiotics, isotretinoin, and potential new therapies like botulinum toxin A and PRP.

A new psoriasis lotion called "Psorisbye" improved symptoms in a patient within one week.

Alopecia areata treatment should consider life quality and mental health, not just clinical results.

Lupus affects the body and skin, causing joint pain and skin issues that can be treated with steroids and antimalarial drugs.

New treatments for hair loss show promise, but more research is needed to confirm their safety and effectiveness.

Anti-TNF therapy can cause a unique type of hair loss that may get better with topical treatments without stopping the therapy.